AboutRobert F
Robert F
Writer · Peptifact
Robert F writes Peptifact's vendor and product documentation. His pages are built from what a seller publishes and what regulators publish about them: certificates of analysis, warning letters, label copy, shipping and price pages — each read on a stated date and linked, so a reader can go and check the same document.
He works to the protocol published on the methodology page. Where a document is missing — no assay, no lot number, no certificate at all — the page says so rather than filling the gap.
He does not tell readers what to use, or how much.
Written by Robert F
- Can Doctors Prescribe Peptides? The Three Routes, What Each One Requires, and Where Telehealth Fits
2026-10-22
- Glutathione vs NAC: The Finished Molecule and Its Building Block, Compared on the Record
2026-10-22
- GMP Peptides: What a 'GMP' Claim Means in Law, What It Means on a Research Label, and How to Check One
2026-10-22
- Increlex vs IGF-1 LR3: The Approved IGF-1 and the Research Analogue, Side by Side
2026-10-22
- Tesamorelin for Women: What the Trials Enrolled, What the Label Says, and What Was Never Measured Separately
2026-10-22
- Glutathione Injection Benefits: Each Claim Set Against the Trials That Injected It
2026-10-20
- The hCG Diet: Where the 500-Calorie Protocol Came From, What the Trials Found, and What Regulators Did
2026-10-20
- hCG for Men: What the Label Approves, What the TRT-Adjunct Use Rests On, and What Was Measured
2026-10-20
- NAD+ Nasal Spray: What the Record Holds — Rodent Studies, One Registered Human Trial, and No Results
2026-10-20
- Sharps Disposal: FDA's Two Steps, the Container Rules, and How Six States Differ
2026-10-20
- AOD-9604 Results: What the Developer's Own Weight-Loss Trials Showed, and Why the Programme Was Stopped in 2007
2026-10-17
- CJC-1295 Results: Every Human Measurement on Record — Hormone Levels Rose, Body Composition Was Never Reported
2026-10-17
- NAD Injection Cost: A Dated Price Survey per Milligram — Clinic Shots, IV Drips and At-Home Plans
2026-10-17
- Peptides and Testosterone: Which Peptides Change It, in Which Direction, and by How Much
2026-10-17
- Sermorelin vs HGH: One Asks the Pituitary, the Other Replaces It — Labels, Trials and the Law That Separates Them
2026-10-17
- BPC-157 for Healing and Inflammation: 231 Papers, Three-Quarters From One Laboratory, and No Controlled Human Trial Yet
2026-10-15
- NAD+ Injection Benefits: What Clinics Claim, What the Trials Measured, and the Outcomes Nobody Has Tested
2026-10-15
- NAD+ Injection vs Oral: What Each Route Was Shown to Do in People, and the Comparison No Trial Has Made
2026-10-15
- Peptides and Breastfeeding: What 13 Approved Labels Say, What the Lactation Database Holds, and the Research Peptides With No Record at All
2026-10-15
- PT-141 for Women: What Vyleesi's Trials Measured in 1,267 Women, How Large the Change Was, and Who It Was Never Tested In
2026-10-15
- Does Insurance Cover Peptides? Approved Drugs Sometimes, Compounded Rarely, Research-Use Never — and the Federal Exclusions That Decide It
2026-10-14
- Kisspeptin for Women: The IVF, Missing-Period and Low-Desire Trials, What Each Measured, and What None of Them Tested
2026-10-14
- MOTS-c Results: What Has Actually Been Measured in People, What Was Only Seen in Mice, and Why 'Before and After' Has No Trial Behind It
2026-10-14
- Peptides Before and After: What the Trials Measured, How Large the Changes Were, and Why a Photo Cannot Tell You
2026-10-14
- TB-500 vs Thymosin Beta-4: Two Molecules Sold Under One Name, and Which One the Trials Actually Used
2026-10-14
- Dihexa vs Semax: One Has a Russian Registration and 451 Treated Children, the Other Has No Human Data and Three Retracted Papers
2026-10-11
- Adamax Dosage: Every Figure Online Is a Vendor Convention, and One 'Adamax' Spray Is Labelled as a Different Molecule
2026-10-11
- Epitalon Side Effects: FDA Found No Human Safety Study, and One Mechanism It Called a Cancer Concern
2026-10-11
- Kisspeptin vs Enclomiphene: Both Raise Testosterone From Above the Testis — One Has Phase 3 Trials and Two Regulatory Refusals, the Other Has Hours-Long Infusions in a Handful of Men
2026-10-11
- VIP Peptide Side Effects: Diarrhoea in a Third, Flushing, Low Blood Pressure — and the Headache Researchers Use It to Cause
2026-10-11
- Adamax vs Semax: A Registered Russian Nasal Drug and a Vendor Name With No Record Anywhere
2026-10-09
- DSIP Side Effects: 209 People, All by Vein, and the One Study Where Blood Pressure Fell
2026-10-09
- Hexarelin vs Ipamorelin: The Stronger Releaser With a Heart Effect, and the Selective One With Surgical Trials
2026-10-09
- Kisspeptin Side Effects: What Five Trial Records Logged, and Why Daily Use Switches the Hormone Off
2026-10-09
- Peptides and Alcohol: What 21 Approved Labels Say, and the One Interaction Study Ever Run
2026-10-09
- BPC-157 Acetate vs Arginate Salt ("Pentadeca Arginate"): Same Peptide, What the Salt Changes, and What the Patent Measured
2026-10-07
- Peptide Patches: What Skin Lets Through, the Two Microneedle Patches That Reached Trials, and the Patches That Contain No Peptide
2026-10-07
- Peptides and Cancer: What the FDA Labels Warn, What Was Measured, and What Nobody Has Tested
2026-10-07
- Sermorelin for Women: Who the Trials Enrolled, What They Measured in Women, and What Changed
2026-10-07
- Sublingual Peptides: The One Approved Under-the-Tongue Peptide Absorbed 0.25% — What That Means for Troches and Drops
2026-10-21
- Are Peptides Safe? Three Different Answers for Three Different Kinds of Product
2026-10-06
- FDA-Approved Peptides: The Full List, Read From Drugs@FDA, With What Is Still on the Market
2026-10-20
- Sermorelin Results: What the Trials Measured, Week by Week, and What the Clinic Timelines Add
2026-10-06
- Sermorelin Tablets, Troches and Nasal Spray: What Was Ever Measured Outside a Syringe
2026-10-06
- Tesamorelin Results: What the Egrifta Trials Measured on CT, What Came Back When It Stopped, and What 'Belly Fat' Means Here
2026-10-06
- Cerebrolysin Side Effects: What the Maker's Handbook, Three Registry Trials and FDA's Database Record
2026-10-05
- Glutathione Injection vs Oral: Two Routes, Two Different Evidence Bases, and No Trial That Compares Them
2026-10-05
- hCG vs Kisspeptin: One Acts at the Gonad for 29 Hours, the Other at the Brain for 28 Minutes
2026-10-05
- Peptide Injection Site Reactions: Ten FDA Labels Compared, and Why the Rate Depends on Who Was Looking
2026-10-05
- Thymosin Alpha 1 Side Effects: A 1,089-Patient Placebo Trial, 248 FDA Reports, and the Subgroup That Went the Wrong Way
2026-10-05
- Thymalin Dosage: The Russian Label's 5 to 20 Milligrams a Day — for a Calf Thymus Extract, Not a Defined Peptide
2026-10-04
- How to Reconstitute hCG: Three FDA Labels, Two Different Diluents, and a 30-Day or 60-Day Clock
2026-10-10
- Ipamorelin Side Effects: Two Surgical Trials, Eleven FDA Reports, and a Safety Claim FDA Never Sourced
2026-10-04
- Oxytocin Side Effects: A Labour-Ward Label, a Nasal Spray With No US Product, and 2,983 FDA Reports That Are Mostly About Pregnancy
2026-10-04
- Peptide Test Kits: What a Colour Card Can Tell You About a Vial, and Why Three of the Most-Sold Peptides Would Look Identical on One
2026-10-04
- Exenatide Dosage: 5 to 10 Micrograms Twice a Day or 2 Milligrams a Week — and Every US Product Now Listed as Discontinued
2026-10-14
- GHRP-2 vs GHRP-6: One Became a Japanese Diagnostic Drug, the Other Has Three Times the Literature and No Approval Anywhere
2026-10-03
- Glutathione Injection Side Effects: The Molecule's Record, the Contamination Record, and 2,110 Reports That Mostly Are Not About It
2026-10-03
- KPV Side Effects: FDA Searched Seven Databases for Any Human Exposure and Found None
2026-10-03
- SS-31 vs MOTS-c: Both Sold as 'Mitochondrial Peptides', but One Has an FDA Label Built on 12 Patients and the Other Has Never Been Tested in a Person
2026-10-03
- 5-Amino-1MQ Side Effects: No Human Data, a 3.5% Oral Figure, and Two Findings the Developers Reported in Passing
2026-10-02
- CJC-1295 vs Sermorelin: Four Amino Acids Apart, and the Only One Measured in People Added 2.4 Minutes
2026-10-02
- CJC-1295 vs Tesamorelin: Two Drugs Raced for the Same Approval in 2005, and Only One Finished
2026-10-02
- Desmopressin Dosage: From 2 Micrograms to 1,200, and Why One Drug Has a 600-Fold Dose Range
2026-10-02
- KLOW and GLOW Peptide Side Effects: Four Records, None of Them for the Blend, and a Copper Load Nobody Has Measured
2026-10-02
- IGF-1 LR3 Side Effects: No Human Data, So Here Is What the Nearest Approved Drug's Label Records
2026-09-30
- NAD+ vs NMN: One Is the Molecule, the Other Is Its Precursor — and the Trials Test Them by Different Routes
2026-09-30
- Oral Peptides: Which Ones Work by Mouth, and How Much of Each Swallowed Dose Reaches the Blood
2026-09-30
- Peptide Nasal Sprays: What Four FDA-Approved Sprays Measured, and What Research Sprays Have Not
2026-10-07
- SLU-PP-332 Side Effects: No Human Has Been Studied, and the Mouse Papers Were Not Designed to Look
2026-10-10
- FOXO4-DRI Dosage: One Mouse Regimen, No Human Trial, and What a 10 mg Vial Represents
2026-09-28
- Orforglipron Dosage: Six Tablet Strengths, and Why the Trial Papers Use Different Numbers
2026-09-28
- Teriparatide Dosage: 20 Micrograms, One Pen a Month, and the Arithmetic That Breaks With a 10 mg Vial
2026-09-28
- PT-141 Side Effects: Nausea in 40%, and the Pigment Finding That Changes With Daily Use
2026-09-28
- Tesamorelin Side Effects: What the Egrifta Labels Measured, and What 1,586 FDA Reports Add
2026-09-28
- AOD-9604 Side Effects: Six Trials, About 900 People, and Not One Subcutaneous Injection
2026-09-27
- Liraglutide Dosage: One Molecule, Two Label Ceilings, and a Rule That Says When to Stop
2026-09-27
- Gonadorelin vs hCG: Two Points on the Same Hormone Axis, and No Trial of the Question Clinics Are Asking
2026-09-27
- What Lyophilized Means for a Peptide: The Process, What the Powder Can Show, and What Four Approved Labels Do With It
2026-09-27
- Semax Side Effects: One Adverse-Event Report, Eight Studies, and Only One That Looked
2026-09-27
- Pinealon Dosage: The Only Published Human Figure Is 100 mcg by Mouth — Vendors Sell 20 mg Vials
2026-09-26
- hCG Side Effects: What the Two US Labels Say, and What 548 FDA Reports Add
2026-09-26
- How Long Do Peptides Take to Work? What the Trials Measured, From 45 Minutes to 72 Weeks
2026-09-26
- How Much Do Peptides Cost? A Dated List-Price Survey of Seven Vendors, per Milligram
2026-09-26
- TB-500 Side Effects: No Human Has Been Studied on It, So Here Is What the Record Does Hold
2026-09-26
- BPC-157 Side Effects: About 80 People in Published Studies, and What FDA's Database Holds
2026-09-28
- Chinese Peptides: What FDA's Own Files Show About Where the Powder Is Made, and What Its Inspectors Found
2026-09-25
- NAD+ Injection Side Effects: Why the Same Drip Was Silent in One Study and Hard to Sit Through in Another
2026-09-25
- Peptide Pens: The Approved Kind Dials a Dose, the Refillable Kind Dials a Volume
2026-09-25
- Peptide Synthesis: How Research Peptides Are Made, and Which of Its By-Products a Purity Figure Never Shows
2026-09-25
- CJC-1295 Side Effects: What 63 Trial Volunteers, One Halted Trial and FDA's 2024 Review Recorded
2026-10-17
- How to Reconstitute Tirzepatide: No Approved Product Needs It, and What the Label's Own Concentrations Show
2026-09-24
- MOTS-c Side Effects: No Human Record, and What Its Closest Relative's Trial Ran Into
2026-09-28
- Peptide Therapy Explained: What Clinics Sell, Which Parts Are Approved, and Where FDA and Its Advisers Split in 2026
2026-09-24
- Tesamorelin vs Ipamorelin: One Has a Label and 543 Treated Trial Patients, the Other Two Surgical Trials
2026-09-24
- Sermorelin Dosage: The Pediatric Label, the Adult Trials, and a Clinic Convention One-Seventh Their Size
2026-09-23
- How to Reconstitute Retatrutide: No Label, a Silent Trial Record, and Arithmetic That Starts From an Untested Number
2026-09-23
- Ipamorelin vs Sermorelin: Two Receptors, Two Paper Trails, and No Trial of Either for What They Are Sold For
2026-09-23
- Sermorelin Side Effects: What the Pediatric Programme, Three Adult Trials and 59 FDA Reports Recorded
2026-09-28
- Who Tests Peptide Vendors? What Each Rating Site Says About Its Samples, Its Labs and Its Money
2026-09-23
- AICAR Dosage: 1,536 People Received It in the Largest Trial, All by Seven-Hour Intravenous Infusion, and the Result Was a Tie
2026-09-21
- Follistatin Dosage: Every Human Administration on Record Is a Gene, Not a Protein, and the Dose Unit Is Not Milligrams
2026-09-21
- GHRP-6 Dosage: A Registry Zero, a Cuban Pharmacokinetic Study, and Two Human Dose Records 250-Fold Apart
2026-09-21
- Gonadorelin Dosage: Every Human Dose Record Is a Pump Schedule, and the Interval Matters More Than the Amount
2026-09-21
- Melanotan 1 Dosage: The Approved Product Is a 16 mg Implant Given Every Two Months, and It Has No Injection Dose at All
2026-09-21
- Cerebrolysin Dosage: The Only Compound Here Dosed in Millilitres, and the One Schedule Cochrane Singles Out by Volume
2026-09-20
- Dihexa Dosage: There Is No Human Dose, No Registered Trial, and Three of the Mechanism Papers Were Retracted in 2025
2026-09-20
- GHRP-2 Dosage: Two Human Dose Records Exist, They Are for Different Purposes, and Retail Pages Quote Neither
2026-09-20
- Survodutide Dosage: The Whole Ladder Is Public, and It Converged on Two Numbers
2026-09-20
- Peptide Half-Life Chart: What the Sources State Compound by Compound, and Why Most of the Famous Numbers Are Not Human
2026-09-22
- Adipotide Dosage: The Human Starting Dose Is in the Public Record, and It Is a Fourteenth of the Monkey Dose Everyone Quotes
2026-09-19
- Oxytocin Dosage: An Approved Label Dosed Per Minute Into a Vein, and a Research Market Dosed Per Puff Up a Nose
2026-09-19
- Peptide Cycle Length: We Searched 141 Registered Trials for the Word 'Cycle' and Found It Once, Where It Meant the Menstrual Cycle
2026-09-19
- Subcutaneous Injection Is the Route of the Approved Analogues, Not of Peptides in General — and the Research Market Applies It to Everything
2026-09-19
- Certificate of Analysis vs Laboratory Report: One Is a Summary the Seller Issues, the Other Is the Record the Regulation Describes — and They Differ on Who Chose the Sample
2026-09-19
- Glutathione Dosage: FDA's Reviewers Recommended Against It, Its Own Advisory Committee Voted 8-5 the Other Way, and Intravenous Half-Life Is 10 to 15 Minutes
2026-09-18
- Noopept Dosage: 106 Papers, Zero Registered Trials, and One Dose Figure — 20 mg a Day, From an Open Study With No Randomisation
2026-09-18
- VIP Dosage: The Largest Trial Dosed It in Picomoles per Kilogram per Hour, and the Whole Three-Day Course Came to Under a Milligram
2026-09-18
- Peptide Fridges: CDC Bans One Common Unit Outright, and Measured Domestic Fridges Are Out of Range for Two Hours and Forty Minutes a Day
2026-09-18
- Where Research Peptides Come From: 95 Registered Suppliers for Semaglutide, and None at All for BPC-157
2026-09-18
- KLOW Dosage: Four Peptides in a Fixed Ratio, So One Number Sets All Four
2026-09-17
- Lipo-C Dosage: Two Pharmacies' Lipo-C Are Not the Same Injection
2026-09-17
- NAD+ Injection Dosage: The Trial Doses Differ From the Clinic Doses by Fifty Times
2026-09-17
- SLU-PP-332 Dosage: Its Own Developers Say It Is Not Orally Available, and It Is Sold as a Tablet
2026-09-17
- Wolverine Stack Dosage: Both Halves Are Now in the Registry, Neither Registration States a Dose
2026-09-17
- hCG Dosage: A Real Label With Real Numbers — That Says Its Own Regimens Were 'Advocated by Various Authorities'
2026-09-16
- Peptide Dosage Chart: 52 Compounds and Blends, and the Ten Incompatible Forms Their Published Doses Take
2026-10-03
- Peptide Injection Sites: Four Approved Labels, Four Different Lists — and None of Them Set by Absorption
2026-09-16
- Peptide Stacks Explained: We Searched the Trial Registry for Every Named Blend and Found Zero
2026-09-16
- Peptide Testing: What Each Assay Measures, and the One a Research COA Usually Leaves Out
2026-09-25
- Kisspeptin Dosage: A Full Human Record, in Units No Vial Label Uses
2026-09-14
- Tesofensine Dosage: Twenty Years of Trials, Four Doses, and No Phase 3
2026-09-14
- "Research Use Only": Two Regulations, Two Different Labels, and the Sentence That Belongs to Neither
2026-09-14
- "Third-Party Tested": What the Claim Commits a Seller To, and the Four Questions It Leaves Open
2026-09-14
- What "USP Grade" Means — and Why the Claim Argues Against the Seller Making It
2026-09-14
- DSIP Dosage: Every Human Study Used a Vein, and the Research Market Sells a Needle
2026-09-13
- Epitalon Dosage: The Human Studies Are About a Different Substance
2026-09-13
- Thymosin Alpha 1 Dosage: The Best-Evidenced Compound on FDA's Withdrawn List
2026-09-13
- FDA's Category 2 List, Indexed: Every Substance, Every Section, Every Date
2026-09-13
- Peptide Side Effects: We Counted FDA's Adverse Event Database, and It Is Almost Empty
2026-09-13
- 503A vs 503B: The Two Kinds of Compounding, and Why They Give Different Answers About the Same Peptide
2026-09-12
- 5-Amino-1MQ Dosage: Four Papers Exist, All of Them in Mice or Cells
2026-09-11
- IGF-1 LR3 Dosage: We Read All 44 Papers and Not One Is a Human Study
2026-09-24
- KPV Dosage: Most of the Research Is About How to Deliver It, Not What a Dose Does
2026-09-24
- SS-31 Dosage: The Molecule Sold as a Research Peptide Now Has an FDA Label
2026-09-11
- Peptide Vials: The Glass Is Pharmaceutical, the Rules Behind It Are Not
2026-09-11
- AOD-9604 Dosage: More Papers on Detecting It Than on What It Does
2026-09-24
- Melanotan II Dosage: One Registration, and It Copies a Real Trial's Design
2026-09-24
- Selank Dosage: Two Randomised Papers, One Journal, and a Search Count That Doubles the Evidence
2026-09-24
- Cagrilintide Dosage: The 2.4 mg Figure Comes From a Trial of the Drug Alone — Almost Nothing Else Does
2026-09-09
- Retatrutide Dosage: Every Circulating Figure Traces to One Trial's Arm Labels
2026-09-22
- Semaglutide Dosage: One Molecule, Five Labelled Dose Ladders, and a 700-Fold Range
2026-09-22
- Tirzepatide Dosage: Two Brands, Identical Strengths, and Three Different Ceilings
2026-09-24
- MOTS-c Dosage: No Label, No Completed Trial, and One Registration Worth Checking
2026-09-24
- PT-141 Dosage: The Approved Label Says 1.75 mg, for a Use Most Buyers Are Not Buying It For
2026-09-08
- Semax Dosage: The Published Figures Are Concentrations, Not Milligrams
2026-09-08
- Are Peptides Legal? What the Rules Actually Say
2026-09-07
- How to Read a Certificate of Analysis, and What One Cannot Tell You
2026-09-06
- Bacteriostatic Water for Injection: Where to Buy It, Ranked
2026-09-05
- Cognitive Peptides, Fact-Checked: Semax, Selank, Noopept, Dihexa, Cerebrolysin and P21
2026-09-05
- BPC-157 Dosage: What Trials, Clinics and Vendor Pages Actually State
2026-09-05
- CJC-1295 and Ipamorelin Dosage: The Trial Doses, the Clinic Doses, and the Gap Between Them
2026-09-05
- GHK-Cu Dosage: Topical Concentrations With Trials, Injectable Figures Without Them
2026-09-05
- How to Read a Peptide Dosing Claim: Units, Sources, and the Questions a Number Has to Answer
2026-09-05
- TB-500 Dosage: What the Fragment Is, What Thymosin Beta-4 Trials Used, and What Guides State
2026-09-05
- Tesamorelin Dosage Chart: EGRIFTA SV and WR Label Doses, the Trial Dose, and Its Half-Life
2026-09-23
- How Peptides Are Reconstituted: The Procedure, the Math, and the Doses Sources Actually Cite
2026-09-05
- How Research Peptides Are Stored: What the Manufacturers' Guides and the Labels Say
2026-09-05
- Insulin Syringes for Peptide Research: What the Markings Mean, What the Law Says, What They Cost
2026-09-05
- FDA Warning Letters to Peptide Vendors: The Tracker (2024 to 2026)
2026-09-07
Peptifact is operated by Sherdas LLC. How this site works.